Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
108 studies found for:    "Biliary tract cancer"
Show Display Options
Rank Status Study
1 Unknown  Second Line Therapy in Advanced Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: capecitabine and mitomycin;   Drug: Capecitabine
2 Active, not recruiting A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer
Conditions: Cholangiocarcinoma;   Biliary Tract Cancer;   Gallbladder Cancer
Interventions: Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Sorafenib
3 Terminated Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer
Conditions: Metastatic Biliary Tract Cancer;   Locally Advanced Biliary Tract Cancer
Interventions: Drug: Gemcitabine, Cisplatin;   Drug: S-1, Cisplatin
4 Completed Vessel Resection and Reconstruction of Biliary Tract Cancers
Condition: Biliary Tract Cancer
Intervention:
5 Completed Case Series Study of Biliary Tract Cancer Patients in Japan
Condition: Biliary Tract Cancer
Intervention:
6 Completed A Population-Based Case-Control Study of Biliary Tract Cancers in Shanghai, China
Condition: Biliary Tract Cancer
Intervention:
7 Enrolling by invitation GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: Gemcitabine/Cisplatin;   Drug: Gemcitabine/Cisplatin /S-1
8 Recruiting GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer
Condition: Biliary Cancer
Interventions: Drug: Irinotecan;   Drug: Cisplatin;   Drug: Gemcitabine
9 Completed Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: Gemcitabine;   Drug: S-1
10 Completed Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer
Condition: Biliary Tract Cancer
Intervention: Drug: S-1, Gemcitabine, Cisplatin
11 Recruiting Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: Gemcitabine;   Drug: S-1
12 Unknown  Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract Cancer
Condition: Biliary Tract Cancer
Intervention: Drug: Docetaxel, Oxaliplatin
13 Completed
Has Results
Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: gemcitabine;   Drug: cisplatin
14 Unknown  Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma)
Condition: Biliary Tract Cancer
Intervention: Drug: S-1 oxaliplatin
15 Recruiting Oral Rehydration Therapy for Short Hydration in Chemotherapy With CDDP Plus GEM for Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: Gemcitabine , Cisplatin, Oral Rehydration Solution (ORS);   Drug: Gemcitabine , Cisplatin
16 Unknown  Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: Fluorouracil;   Drug: Leucovorin;   Drug: Oxaliplatin;   Drug: Irinotecan
17 Recruiting A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy
Condition: Biliary Tract Cancer
Intervention: Drug: Gemcitabine, S-1
18 Completed A Phase I Study of Adjuvant Chemotherapy With GC in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy
Condition: Biliary Tract Cancer
Intervention: Drug: gemcitabine , cisplatin
19 Recruiting A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node Metastasis
Condition: Biliary Tract Cancer
Intervention: Drug: Gemcitabine, Cisplatin, S-1
20 Recruiting Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers
Conditions: Biliary Tract Cancer;   Gallbladder Cancer;   Cholangiocarcinoma;   Ampullary Cancer
Interventions: Other: Active Symptom Control;   Drug: L-folinic acid;   Drug: 5 FU;   Drug: Oxaliplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years